Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-CA-17-046

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01)

Closed on January 16, 2018.

Posted
October 10, 2017
Close date
January 16, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$827,765
$1,655,530 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL1
  2. WEILL MEDICAL COLL OF CORNELL UNIV1

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 RTRB-F (A1))2
2 awards under RFA-CA-17-046 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2018Neoantigen Vaccination for Lynch Syndrome Immunoprevention1U01CA233056-01Lipkin, Steven MVilar Sanchez, EduardoWEILL MEDICAL COLL OF CORNELL UNIV, NYFirst-year cost $853,661Study section ZCA1
FY2018Epithelium-derived alarmins role in breast cancer immunoprevention1U01CA233097-01Demehri, ShadmehrMASSACHUSETTS GENERAL HOSPITAL, MAFirst-year cost $801,869Study section ZCA1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-21-0.3.10. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-CA-17-046: Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01) | ConductScience ScienceDex